$3.260
-0.162 (-4.96%)收盘时
价格预测
在 App 中打开以解锁更长周期的预测。
FEMY 相似图表分析预测
Alphio's FEMY stock price prediction model matches the current Femasys Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.27 (+0.32%). The 1-week path is $3.32 (+1.77%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
该买入 Femasys Inc 股票吗?
Femasys Inc is a good buy right now due to its recent partnership with UNC Health and FDA approval for FemBloc technology, which could significantly boost its market presence. The current price is $3.20, and the RSI is at 71.972, indicating strong momentum. However, the main risk is the negative net income of -4,469,095 USD in Q2 2026, which highlights ongoing financial challenges.
FEMY 股价于 Tuesday 收于 $3.26,此前下跌 -4.96%
Femasys Inc (FEMY) last closed at $3.26, losing -4.96%. These facts feed the 1-day and 1-week FEMY price prediction above.
预测驱动因素
Femasys Inc(FEMY)的预测驱动因素综合了相似的图表形态、季节性与移动平均线。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
相似图表形态
近期走势与 FEMY 最接近的股票,按相似度排序。
FEMY 季节性分析
Historically the probability of a positive September return for FEMY is 47.62%. March offers the highest probability of a positive month at 65.08%, while August is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
FEMY 十年价格预测
| 月份 | 最低价 | 平均价 | 最高价 | 潜在回报率 |
|---|---|---|---|---|
| Sep 2026 | $2.18 | $2.53 | $2.75 | -22.38% |
| Oct 2026 | $2.25 | $2.50 | $2.66 | -23.21% |
| Nov 2026 | $2.43 | $2.53 | $2.92 | -22.38% |
| Dec 2026 | $1.87 | $2.07 | $2.23 | -36.62% |
2026 年,Femasys Inc(FEMY)预计区间为 $1.87 至 $2.92。
Femasys Inc 2026 年月度预测
2026 年 Sep,Femasys Inc 预计均价 $2.53,最低 $2.18,最高 $2.75。
2026 年 Oct,Femasys Inc 预计均价 $2.50,最低 $2.25,最高 $2.66。
2026 年 Nov,Femasys Inc 预计均价 $2.53,最低 $2.43,最高 $2.92。
2026 年 Dec,Femasys Inc 预计均价 $2.07,最低 $1.87,最高 $2.23。
本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。